Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy

SIMPLE SUMMARY: Recently, high-risk prostate cancer was subdivided to a very-high-risk group considered to have the worst prognosis, including clinical stage T3b–T4, primary Gleason pattern 5, or more than four biopsy cores with Gleason score 8–10. Among these, T3b–T4 stage is a special interest in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Hideya, Suzuki, Gen, Masui, Koji, Aibe, Norihiro, Shimizu, Daisuke, Kimoto, Takuya, Yoshida, Ken, Nakamura, Satoaki, Okabe, Haruumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070084/
https://www.ncbi.nlm.nih.gov/pubmed/33924563
http://dx.doi.org/10.3390/cancers13081856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070084/
https://www.ncbi.nlm.nih.gov/pubmed/33924563
http://dx.doi.org/10.3390/cancers13081856

Ejemplares similares